Monitoring of Interfractional Proton Range Verification and Dosimetric Impact Based on Daily CBCT for Pediatric Patients with Pelvic Tumors

被引:1
|
作者
Ates, Ozgur [1 ]
Uh, Jinsoo [1 ]
Pirlepesov, Fakhriddin [1 ]
Hua, Chia-Ho [1 ]
Merchant, Thomas E. [1 ]
Krasin, Matthew J. [1 ]
机构
[1] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
关键词
proton range uncertainty; water equivalent path length; pediatric pelvic tumors; interfractional range verification; synthetic CT; RADIOTHERAPY; THERAPY;
D O I
10.3390/cancers15174200
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary The research highlights the application of synthetic CT images, which are created by deforming planning CT scans to match daily CBCT anatomy in interfractional proton therapy for pediatric patients with pelvic tumors. The objective of the study is to identify changes in the proton path length and determine the impact of anatomical changes on the treatment plan's quality. The findings reveal that the water equivalent path length method can effectively estimate proton range deviations on synthetic-CT images. The daily synthetic CT images can also be utilized as a surrogate to calculate dose and predict dosimetric changes in the plan of the day. This approach eliminates the need for frequent rescanning, thereby making the adaptive therapy process more streamlined and less burdensome for young patients. The results have the potential to improve the precision of proton therapy, hence paving the way for more effective treatments.Abstract (1) Background: Synthetic CT images of the pelvis were generated from daily CBCT images to monitor changes in water equivalent path length (WEPL) and determine the dosimetric impact of anatomy changes along the proton beam's path; (2) Methods: Ten pediatric patients with pelvic tumors treated using proton therapy with daily CBCT were included. The original planning CT was deformed to the same-day CBCT to generate synthetic CT images for WEPL comparison and dosimetric evaluation; (3) Results: WEPL changes of 20 proton fields at the distal edge of the CTV ranged from 0.1 to 12 mm with a median of 2.5 mm, and 75th percentile of 5.1 mm for (the original CT-rescanned CT) and ranged from 0.3 to 10.1 mm with a median of 2.45 mm and 75th percentile of 4.8 mm for (the original CT-synthetic CT). The dosimetric impact was due to proton range pullback or overshoot, which led to reduced coverage in CTV Dmin averaging 12.1% and 11.3% in the rescanned and synthetic CT verification plans, respectively; (4) Conclusions: The study demonstrated that synthetic CT generated by deforming the original planning CT to daily CBCT can be used to quantify proton range changes and predict adverse dosimetric scenarios without the need for excessive rescanned CT scans during large interfractional variations in adaptive proton therapy of pediatric pelvic tumors.
引用
收藏
页数:10
相关论文
共 34 条
  • [1] Proton Interfractional Range Verification in Pediatric Patients for Pelvic Tumors Based On Synthetic CT
    Ates, O.
    Hua, C.
    Uh, J.
    Fakhriddin, P.
    Zhao, L.
    Krasin, M.
    MEDICAL PHYSICS, 2018, 45 (06) : E127 - E127
  • [2] Study On Interfractional Range Reduction by Range-Based Registration Using Daily CBCT for Pelvic and Abdominal Sarcoma Patients Treated by Intensity-Modulated Proton Therapy
    Yao, W.
    Windmueller, R.
    Harikumar, V.
    Ates, O.
    Krasin, M.
    MEDICAL PHYSICS, 2018, 45 (06) : E403 - E403
  • [3] Interfractional Monitoring of Body Surface Changes Via Daily CBCT Imaging for Adaptive Proton Therapy
    Lee, H.
    Hua, C. H.
    Krasin, M.
    Merchant, E.
    Ates, O.
    Uh, J.
    MEDICAL PHYSICS, 2024, 51 (10) : 7680 - 7681
  • [4] Interfractional Dosimetric Verification of Lung Patients Treated by Passive Double Scattering Proton Radiotherapy
    Tang, S.
    Yin, L.
    Rengan, R.
    James, P.
    Hahn, S.
    Both, S.
    MEDICAL PHYSICS, 2012, 39 (06) : 3805 - 3805
  • [5] Evaluation of the dosimetric impact of interfractional anatomical variations on prostate proton therapy using daily in-room CT images
    Wang, Yi
    Efstathiou, Jason A.
    Sharp, Gregory C.
    Lu, Hsiao-Ming
    Ciernik, I. Frank
    Trofimov, Alexei V.
    MEDICAL PHYSICS, 2011, 38 (08) : 4623 - 4633
  • [6] Image-Based Proton Range Verification Using Intensity-Corrected CBCT
    Yin, L.
    Dolney, D.
    Kassaee, A.
    Gee, J.
    Ahn, P.
    Lin, A.
    McDonough, J.
    Maughan, R.
    MEDICAL PHYSICS, 2013, 40 (06)
  • [7] Clinical Outcomes of Pediatric Patients With Pelvic Tumors Treated With Proton Therapy
    Tann, A. W. J.
    McAleer, M. F.
    McGovern, S. L.
    Grosshans, D. R.
    Huh, W.
    Paulino, A. C.
    Mahajan, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E555 - E555
  • [8] Comparing the dosimetric impact of interfractional anatomical changes in photon, proton and carbon ion radiotherapy for pancreatic cancer patients
    Houweling, Antonetta C.
    Crama, Koen
    Visser, Jorrit
    Fukata, Kyohei
    Rasch, Coen R. N.
    Ohno, Tatsuya
    Bel, Arjan
    van der Horst, Astrid
    PHYSICS IN MEDICINE AND BIOLOGY, 2017, 62 (08): : 3051 - 3064
  • [9] Feasibility study of in vivo MRI based dosimetric verification of proton end-of-range for liver cancer patients
    Yuan, Yading
    Andronesi, Ovidiu C.
    Bortfeld, Thomas R.
    Richter, Christian
    Wolf, Russell
    Guimaraes, Alexander R.
    Hong, Theodore S.
    Seco, Joao
    RADIOTHERAPY AND ONCOLOGY, 2013, 106 (03) : 378 - 382
  • [10] Assessment of dosimetric impact of interfractional 6D setup error in tongue cancer treated with IMRT and VMAT using daily kV-CBCT
    Shinde, Prashantkumar
    Jadhav, Anand
    Shankar, V.
    Dhoble, Sanjay J.
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2023, 28 (02) : 224 - 240